Genoa Ventures

Genoa Ventures stands at the intersection of biology and technology, investing in early-stage companies that are poised to revolutionize their industries. Their portfolio includes trailblazing startups like Ionpath and BRAINBox Solutions, reflecting a keen focus on research tools, diagnostics, Agri/Food Bio, and industrial biology. Headquartered in San Francisco, Genoa has a strong geographic focus on North America. Genoa's investment strategy zeroes in on seed and Series A rounds, aiming to be an active partner rather than just a financial backer. The firm typically leads rounds with average checks ranging from $500K to $5M. Their approach emphasizes long-term relationships and strategic guidance, leveraging the team's extensive background in scientific research, technology development, and entrepreneurship. This hands-on involvement ensures that portfolio companies receive the support they need to scale effectively. The team is led by founder and managing director Jenny Rooke, Ph.D., who has a rich background in both the scientific and investment realms. Genoa's partners bring a unique blend of experience, having worked across various capacities in the life sciences and tech sectors. This diverse expertise enables Genoa to identify and nurture companies that others might overlook. For startups looking to engage with Genoa, it's best to approach them with a clear demonstration of how their technology intersects with biology to solve significant problems. The firm values early identification of technological advantages and market potential, making them a pivotal partner in driving innovation forward.